Rain Oncology Inc. Deferred Tax Assets, Net of Valuation Allowance
Rain Oncology Inc. had Deferred Tax Assets, Net of Valuation Allowance of $75.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-03-09
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $75.00K.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $81.00K.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $133.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2022-12-31 | $75.00K 10-K · filed 2023-03-09 |
| 2021-12-31 | $81.00K 10-K · filed 2023-03-09 |
| 2020-12-31 | $133.00K 10-K · filed 2022-03-03 |